Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Clinical and Experimental Pharmacology & Physiology|November 1, 1975
Control of hindlimb vascular resistance in rats chronically sympathectomized with 6-hydroxydopamineD W Clark, E L PhelanJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Effect of verapamil and sodium nitroprusside on hindlimb vascular resistance in New Zealand genetically hypertensive and Japanese spontaneously hypertensive ratsE L Phelan, F O SimpsonJournal of Autonomic Pharmacology|April 1, 1992
Renal alpha 2-adrenoceptors in New Zealand genetically hypertensive ratsD D Smyth, E L Phelan, C StankoBritish Journal of Pharmacology|February 1, 1972
Long-lasting peripheral and central effects of 6-hydroxydopamine in ratsD W Clark, R Laverty, E L PhelanJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1986
Electrolytes and spontaneous genetic hypertension in ratsF O Simpson, J Ledingham, E L PhelanClinical and Experimental Pharmacology & Physiology|May 1, 1993
Effects of cilazapril on the structure of mesenteric resistance arteries of New Zealand genetically hypertensive and normotensive control ratsJ M Ledingham, E L Phelan, J A MillarJournal of Cardiovascular Pharmacology|January 1, 1984
Body sodium level in hypertensive and normotensive rats: effects of dietary sodium levels and sodium loadsF O Simpson, J M Ledingham, E L PhelanClinical and Experimental Pharmacology & Physiology|July 1, 1975
Cardiovascular effects of prazosin in normotensive and genetically hypertensive ratsA J Wood, E L Phelan, F O SimpsonExperientia|July 15, 1983
24-h exchangeable sodium in genetically hypertensive and normotensive ratsJ M Ledingham, E L Phelan, F O SimpsonJournal of Vascular Research|April 8, 2000
Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipineJ M Ledingham, E L Phelan, M A Cross, et al.Pageof 2